Gene · 5268
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity. | Biomedicines | 2023 | 37239055 | PubTator, text mining | PubMed |
| Augmenting the Angiogenic Profile and Functionality of Cord Blood Endothelial Colony-Forming Cells by Indirect Priming with Bone-Marrow-Derived Mesenchymal Stromal Cells. | Biomedicines | 2023 | 37239042 | PubTator, text mining | PubMed |
| Targeted DNA Demethylation: Vectors, Effectors and Perspectives. | Biomedicines | 2023 | 37239005 | PubTator, text mining | PubMed |
| Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling. | Front Endocrinol (Lausanne) | 2023 | 37234801 | PubTator, text mining | PubMed |
| Current Molecular, Cellular and Genetic Aspects of Peri-Implantitis Disease: A Narrative Review. | Dent J (Basel) | 2023 | 37232785 | PubTator, text mining | PubMed |
| Functional and Clinical Proteomic Exploration of Pancreatic Cancer. | Mol Cell Proteomics | 2023 | 37209817 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective. | Mol Cell Proteomics | 2023 | 37209814 | PubTator, text mining | PubMed |
| Molecular vasculogenic mimicry-Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts. | Front Pharmacol | 2023 | 37197406 | PubTator, text mining | PubMed |
| Endocrine Disruptors in Food, Estrobolome and Breast Cancer. | J Clin Med | 2023 | 37176599 | PubTator, text mining | PubMed |
| Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes. | Elife | 2023 | 37158593 | PubTator, text mining | PubMed |
| Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation. | Nat Commun | 2023 | 37156840 | PubTator, text mining | PubMed |
| A nomogram based on genotypic and clinicopathologic factors to predict the non-sentinel lymph node metastasis in Chinese women breast cancer patients. | Front Oncol | 2023 | 37152050 | PubTator, text mining | PubMed |
| Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma. | Clin Epigenetics | 2023 | 37120619 | PubTator, text mining | PubMed |
| Correlation between Maspin Levels in Different Biological Samples and Pathologic Features in Colorectal Adenocarcinomas. | Life (Basel) | 2023 | 37109589 | PubTator, text mining | PubMed |
| By using machine learning and in vitro testing, SERPINH1 functions as a novel tumorigenic and immunogenic gene and predicts immunotherapy response in osteosarcoma. | Front Oncol | 2023 | 37091161 | PubTator, text mining | PubMed |
| Proteomic profiling of cutaneous melanoma explains the aggressiveness of distant organ metastasis. | Exp Dermatol | 2023 | 37082900 | PubTator, text mining | PubMed |
| IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis. | Sci Rep | 2023 | 37069240 | PubTator, text mining | PubMed |
| Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis. | Front Oncol | 2023 | 37064125 | PubTator, text mining | PubMed |
| Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction. | Front Immunol | 2023 | 37063830 | PubTator, text mining | PubMed |
| The most likely but largely ignored triggering factor for breast (or all) cancer invasion. | J Cancer | 2023 | 37057291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5268/papers?page=9